Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison

  • Els K. Vanhoutte
  • , Thomas H. P. Draak
  • , Kenneth C. Gorson
  • , Sonja I. van Nes
  • , Janneke G. J. Hoeijmakers
  • , W. -Ludo Van der Pol
  • , Nicolette. C. Notermans
  • , Richard A. Lewis
  • , Eduardo Nobile-Orazio
  • , Jean-Marc Leger
  • , Peter Y. K. Van den Bergh
  • , Giuseppe Lauria
  • , Vera Bril
  • , Hans Katzberg
  • , Michael P. T. Lunn
  • , Jean Pouget
  • , Anneke J. van der Kooi
  • , Angelika F. Hahn
  • , Pieter A. van Doorn
  • , David R. Cornblath
  • Leonard H. van den Berg, Catharina G. Faber, Ingemar S. J. Merkies*
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

This study aimed to define responder' through the concept of minimum clinically important differences using the individually obtained standard errors (MCID-SE) and a heuristic external criterion' responsiveness method in patients with Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). One hundred and fourteen newly diagnosed or relapsing patients (GBS: 55, CIDP: 59) were serially examined (1-year follow-up). The inflammatory Rasch-built overall disability scale (I-RODS), Rasch-transformed MRC sum score (RT-MRC), and Rasch-transformed modified-INCAT-sensory scale (RT-mISS) were assessed. Being-a-responder was defined as having a MCID-SE cut-off 1.96. Also, the correlations between patients' scores on each scale and the EuroQoL health-status thermometer' (external criterion) were determined (higher correlation indicated better responsiveness). In both diseases, the SEs showed a characteristic U'-shaped dynamic pattern across each scales' continuum. The number of patients showing a meaningful change were higher for the I-RODS>RT-MRC>RT-mISS and were in GBS higher than CIDP patients. The MCID-SE concept using Rasch-transformed data demonstrated an individual pattern of being-a-responder' in patients with immune-mediated neuropathies, and the findings were validated by the external criterion responsiveness method. The I-RODS showed greater responsiveness compared with the MRC and INCAT-sensory scales, and its use is therefore recommended in future trials in GBS and CIDP.
Original languageEnglish
Pages (from-to)289-295
Number of pages7
JournalJournal of the Peripheral Nervous System
Volume20
Issue number3
DOIs
Publication statusPublished - Sept 2015

Keywords

  • immune-mediated neuropathies
  • minimum clinically important difference
  • outcome measure
  • Rasch

Fingerprint

Dive into the research topics of 'Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison'. Together they form a unique fingerprint.

Cite this